No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Dr. Bernd Saugel Joins the Retia Medical Clinical Advisory Board

Editor: What To Know

  • Saugel is also the Chair of the Scientific Subcommittee 14 (monitoring, ultrasound and equipment) of the European Society of Anesthesiology and Intensive Care (ESAIC) and the Deputy Chair of the Cardiovascular Dynamics Section of the European Society of Intensive Care Medicine (ESICM).
  • “We look forward to working with him as a recognized leader in peri-operative and critical care to help streamline the use of hemodynamic monitoring in clinical practice and guide our efforts to develop novel algorithms and devices that can help clinicians prevent complications in high-risk patients.
  • Bernard Saugel is a Full Professor of Anesthesiology and Vice Chair in the Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine of the University Medical Center Hamburg-Eppendorf (Hamburg, Germany).

Retia Medical, an innovator in hemodynamic monitoring that helps clinicians guide care to prevent complications from high-risk surgeries such as heart attacks, strokes, and acute kidney injuries, today announced that Bernd Saugel, MD, EDIC joins other distinguished clinicians on Retia Medical’s Clinical Advisory Board.

Dr. Bernard Saugel is a Full Professor of Anesthesiology and Vice Chair in the Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine of the University Medical Center Hamburg-Eppendorf (Hamburg, Germany).

Segal has published more than 190 original articles and didactic reviews in peer-reviewed journals and serves as Associate Editor (Cardiovascular) of the Journal of Clinical Monitoring and Computing and as Section Editor (Cardiovascular) of the Journal of Critical Care.   Dr. Saugel is also the Chair of the Scientific Subcommittee 14 (monitoring, ultrasound and equipment) of the European Society of Anesthesiology and Intensive Care (ESAIC) and the Deputy Chair of the Cardiovascular Dynamics Section of the European Society of Intensive Care Medicine (ESICM).

As a Visiting Professor he collaborates with the Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, USA (Chair: Prof. Dr. Daniel I. Sessler) and he is a Major Regional Director of the Outcomes Research Consortium, Cleveland, OH, USA.

His main field of research is the hemodynamic management of high-risk patients having surgery and critically ill patients. He especially focuses on concepts of “personalized hemodynamic management” using advanced innovative hemodynamic monitoring methods in perioperative and intensive care medicine.

“We are delighted to welcome Dr. Saugel to our Clinical Advisory Board,” said Marc Zemel, S.M., M.B.A., co-founder and Chief Executive Officer of Retia Medical. “We look forward to working with him as a recognized leader in peri-operative and critical care to help streamline the use of hemodynamic monitoring in clinical practice and guide our efforts to develop novel algorithms and devices that can help clinicians prevent complications in high-risk patients.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy